Which level of cytokine production is critical in haemodialysis?

Nephrology Dialysis Transplantation

Volumn 13, Issue SUPPL. 7, 1998, Pages 55-60

  Cappelli, G ^a   DiFelice, A ^a   Perrone, S ^a   Ballestri, M ^a   Bonucchi, D ^a   Savazzi, A M ^a   Ciuffreda, A ^a   Lusvarghi, E ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; COMPLEMENT; CYTOKINE; DIALYSIS FLUID; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR;

BIOCOMPATIBILITY; CONFERENCE PAPER; CONTAMINATION; CYTOKINE PRODUCTION; DIALYSATE; HEMODIALYSIS; HUMAN; LEUKOCYTE ACTIVATION; MONOCYTE; PRIORITY JOURNAL; UREMIA;

EID: 0031758784     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.suppl_7.55     Document Type: Conference Paper

References (66)

1. Colton CK, Ward RA, Shaldon S. Scientific basis for assessment of biocompatibility in extracorporeal blood treatment. Nephrol Dial Transplant 1994; 9 [Suppl 2]: 11 17
2. Henderson LW, Koch KM, Dinarello CA, Shaldon S. Hemodialysis hypotension: the interleukin hypothesis. Blood Purification 1983; 1: 3 8
3. Pereira BJG, Dinarello CA. Production of cytokines and cytokine inhibitory proteins in patients on dialysis. Nephrol Dial Transplant 1994; 9 [Suppl 2]: 60-71
4. Dinarello CA. Cytokines: agents provocateurs in hemodialysis. Kidney Int 1992; 41: 683 694
5. Schindler R, Gelfand JA, Dinarello CA. Recombinant C5a stimulates transcription rather than translation of IL-1 and TNF: translational signal provided by LPS or IL-1 itself. Blood 1990; 76: 1631 1638
6. Haeffner CN, Cavaillon JM, Laude M, Kazatchkine MD. C3a (C3adesArg) induces production and release of interleukin 1 by cultured human monocytes. J Immunol 1987; 139: 794-799
7. Schindler R, Linnenweber S, Schulze M. et al. Gene expression of interleukin-1β during hemodialysis. Kidney Int 1993; 43: 712-721
8. Wilde CG, Seilhamer JJ, McGrogan M et al. Bactericidal/permeability-increasing protein and lipopolysaccharide (LPS)-binding protein. J Biol Chem 1994; 269: 17411-17416
9. Jungi TW, Breic M, Eperon S. Human macrophages respond to LPS in a serum independent, CD14 dependent manner. Immunol Lett 1996; 54: 37-43
10. Abel G, Czop JK. Stimulation of human monocyte beta-glucan receptors by glucan particles induces production of TNF-alpha and IL-1 beta, Int J Immunopharmacol 1992; 14: 1363-1373
11. Poutsiaka DD, Mengozzi M, Vannier E, Sinha B, Dinarello CA. Cross-linking of the beta-glucan receptor on human monocytes results in interleukin-1 receptor antagonist but not interleukin-1 production. Blood 1993; 82: 3695 3700
12. Deppisch R, Ritz E, Hansch GM, Schols M, Rauterberg EW. Bioincompatibility - perspectives in 1993. Kidney Int 1994; 45 [Suppl 44]: S77-S84
13. Mahiout A, Lonnemann G, Schulze M, Schindler R, Shaldon S, Kock KM. Low molecular weight. LAL-negative substances from Pseudomonas induce cytokines from mononuclear cells. (abstract) J Am Soc Nephrol 1990; 1: 367
14. Bhakdi S, Klonisch T, Nuber P, Fischer W. Stimulation of monokine production by lipoteichoic acids. Infect Immun 1991; 59: 4614-4620
15. Bingel M, Lonnemann G, Koch KM, Dinarello CA, Shaldon S. Enhancement of in-vitro human interleukin-1 production by sodium acetate. Lancet 1987; 1: 14-17
16. Schindler R, Lonnemann G, Shaldon S, Koch KM, Dinarello CA. Transcription, not synthesis, of interleukin-1 and tumor necrosis factor by complement. Kidney Int 1990; 37: 85 93
17. Bommer J, Weinreich T, Lovett DH, Bouillon R, Ritz E, Gemsa D. Particles from dialysis tubing stimulate interleukin-1 secretion by macrophages. Nephrol Dial Transplant 1990; 5: 208-213
18. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991; 77: 1627-1652
19. Laude-Sharp M, Haeffner-Cavaillon N, Caroff M, Lantreibecq F, Pusineri C, Kazatchkine MD. Dissociation between the interleukin 1-inducing capacity and Limulus reactivity of lipopolysaccharides from gram-negative bacteria. Cytokine 1990; 2: 253-258
20. Rietschel ET, Kirikae T, Ulrich-Shade F et al. The chemical structure of bacterial endotoxin in relation to bioactivity. Immunobiology 1993; 187: 169-190
21. Lynn WA, Golenbock DT. Lipopolysaccharide antagonists. Immunol Today 1992; 13: 271-276
22. Nocker WA, Scherberich JE. Monocyte cell-surface CD14 expression and soluble CD14 antigen in hemodialysis: evidence for chronic exposure to LPS. Kidney Int 1995; 48: 1469-1476
23. Wilde CG, Seilhamer JJ, McGrogan M et al. Bactericidal/permeability-increasing protein and lipopolysaccharide (LPS)-binding protein. J Biol Chem 1994; 269: 17411-17416
24. Pereira BJ Sundaram S, Snodgrass B, Hogan P, King AJ. Plasma lipopolysaccharide binding protein and bactericidal/permeability increasing factor in CRF and HD patients. J Am Soc Nephrol 1996; 7: 479-487
25. Yamagami S, Adachi T, Sugimura T et al. Detection of endotoxin antibody in long term dialysis patients. Int J Artif Org 1990; 13: 205-210
26. Weinstock C, Ullrich H, Hohe R et al. Low density lipoproteins inhibit endotoxin activation of monocytes. Arterioscler Thromb 1992; 12: 341 347
27. Eggesb JB, Hjermann IH, Kierulf P. LPS induced release of IL-1 beta, IL-6, IL-8 and TNF-alpha in EDTA or heparin anticoagulated whole blood from persons with high or low levels of serum HDL. Cytokine 1996; 8: 152-160
28. Santamaria P, Gehrz RC, Bryan MK, Barbosa JJ. Involvement of class II MHC molecules in the LPS-induction of IL-1/TNF secretions by human monocytes. Quantitative differences at the polymorphic level. J Immunol 1989; 143: 913-922
29. Tsukamoto Y, Nagaba Y, Izumida I, Morishita T, Saitoh M. Comparison of effects of calcitriol and calcium carbonate on secretion of interleukin-1 beta and tumour necrosis factor-alpha by uraemic peripheral blood mononuclear cells. Nephrol Dial Transplant 1996; 11 [Suppl 3]: 15-21
30. Sunder-Plassmann G, Sedlacek PL, Sunder-Plassmann R et al. Anti-interleukin-1α autoantibodies in hemodialysis patients. Kidney Int 1991; 40: 787-791
31. Lonnemann G, Barndt I, Kaever V et al. Impaired endotoxininduced interleukin-1β secretion, not total production, of mononuclear cells from ERSD patients. Kidney Int 1995; 47: 1158-1167
32. Perregaux DG, Laliberte RE, Gabel CA. Human monocyte interleukin-1 beta posttranslational processing. Evidence of a volume-regulated response. J Biol Chem 1996; 271: 29830-29838
33. Koropatnick J, Zalups RK. Effect of non toxic mercury, zinc or cadmium pretreatment on the capacity of human monocytes to undergo lipopolysaccharide induced activation. Br J Pharmacol 1997; 120: 797-806
34. Engstad CS, Gutteberg TJ, Osterud B. Modulation of blood cell activation by four commonly used anticoagulants. Thromb Haemostasis 1997; 77: 690-696
35. Gafter U, Kalechman Y, Orlin JB, Levi J, Sredni B. Anemia of uremia is associated with reduced in vitro cytokine secretion: immunopotentiating activity of red blood cells. Kidney Int 1994; 45: 224-231
36. Pereira BJG, Shapiro L, King AJ, Falagas ME, Strom JA, Dinarello CA. Plasma levels of IL-1β. TNFα and their specific inhibitors in undialyzed chronic renal failure. CAPD and hemodialysis patients. Kidney Int 1994; 45: 890 896
37. Nocker WA, Scherberich JE. Monocyte cell-surface CD14 expression and soluble CD14 antigen in hemodialysis: evidence for chronic exposure to LPS. Kidney Int 1995; 48: 1469-1476
38. Zaoui P, Hakin RM. The effect of the dialysis membrane on cytokine release. J Am Soc Nephrol 1994; 4: 1711-1718
39. Born J, Uthgenannt D, Dodt C et al. Cytokine production and lymphocyte subpopulations in aged humans. An assessment during nocturnal sleep. Mech Ageing Dev 1995; 84: 113-126
40. McLachlan JA, Serkin CD, Morrey KM, Bakouche O. Antitumoral properties of aged human monocytes. J Immunol 1995; 154: 832-843
41. McLachlan JA, Serkin CD, Morrey-Clark KM, Bakouche O. Immunological functions of aged human monocytes. Pathobiology 1995; 63: 148-159
42. Catania A, Airaghi L, Motta P et al. Cytokine antagonists in aged subjects and their relation with cellular immunity. J Gerontol A Biol Sci Med Sci 1997; 52: B93-B97
43. American National Standards for Hemodialyis Systems. In AAMI: Standards and Recommended Practices. Arlington: 1990; Vol 3: 35-548
44. Council of Europe: water for diluting concentrated haemodialysis solutions. European Pharmacopoeia. 2nd edn, Maisonneuve S.A., St-Ruffine; France: 1992; part II, 16th fascicule: VIII.9
45. Orlinska U, Newton RC. Role of glucose in interleukin-1 beta production by lipopolysaccharide-activated human monocytes. J Cell Physiol 1993; 157: 201-208
46. Orlinska U, Newton RC. Effects of intracellular ions on interleukin-1 beta production by lipopolysaccharide-activated human monocytes. Am J Physiol 1992; 263: C1073-C1080
47. Tominaga H, Tanaka S, Tominaga N. Endotoxin level of sterile injection solutions and substitution fluid for hemofiltration in Japan and Australia. Nephron 1986; 42: 128-132
48. Lynch EA, Dinarello CA, Cannon JG. Gender differences in IL-1 alpha. IL-1 beta, and IL-1 receptor antagonist secretion from mononuclear cells and urinary excretion. J Immunol 1994; 153: 300 306
49. Fielding RA, Manfredi TJ, Ding W, Fiatarone MA, Evans WJ, Cannon JG. Acute phase response in exercise. III. Neutrophil and IL-1β accumulation in skeletal muscle. Am J Physiol 1993; 265: R166 R172
50. Venkatraman JT, Fernandes G. Exercise, immunity and aging. Aging Clin Exp Res 1997; 9: 42-56
51. Andersson J, Bjork L, Dinarello CA, Towbin H, Andersson U. Lipopolysaccharide induces human interleukin-1 receptor antagonist and interleukin-1 production in the same cell. Eur J Immunol 1992; 22: 2617 2623
52. Dinarello CA. Interleukin-1 and interleukin-1 receptor antagonist production during haemodialysis: which cytokine is a surrogate marker for dialysis-related complications? Nephrol Dial Transplant 1995; 10 [Suppl 3]: 25-28
53. Schindler R, Lonnemann G, Schaffer J, Shaldon S, Kock KM, Krautzig S. The effect of ultrafiltered dialysate on the cellular content of interleukin-1 receptor antagonist in patients on chronic hemodialysis. Nephron 1994; 68: 229-233
54. Memoli B, Libetta C, Rampino T et al. Hemodialysis related induction of interleukin-6 production by peripheral blood mononuclear cells. Kidney Int 1992; 42: 320-326
55. Moutabarrik A, Takahara S, Namiki M et al. Contrasting effects of interferon-gamma and interleukin-4 on neopterin generation from human adherent monocytes. Lymphokine Cytokine Res 1992; 11: 327 330
56. Kojima S, Icho T, Kajiwara Y, Kubota K. Neopterin as an endogenous antioxidant. FEBS Lett 1992; 304: 163 166
57. Godai K, Uemasu J, Kawasaki H. Clinical significance of serum and urinary neopterins in patients with chronic renal disease. Clin Nephrol 1991; 36: 141-146
58. Tilg H, Vannier E, Vachino G, Dinarello CA, Mier JW. Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells. J Exp Med 1993; 178: 1629-1636
59. Engler R. Proteins of the inflammatory reaction. Regulatory functions. Ann Biol Clin Paris 1988; 46: 33-342
60. Rokita H, Loose LD, Bartle LM, Sipe JD. Synergism of interleukin 1 and interleukin 6 induces serum amyloid A production while depressing fibrinogen: a quantitative analysis. J Rheumatol 1994; 21: 400-405
61. Docci D, Bilancioni R, Baldrati L, Capponcini C, Turci F, Feletti C. Elevated acute phase reactants in hemodialysis patients. Clin Nephrol 1990; 34: 88-91
62. Honkanen E, Gronhagen-Riska C, Teppo AM, Maury CPJ. Meri S. Acute-phase proteins during hemodialysis: correlations with serum interleukin-1β levels and different dialysis membranes. Nephron 1991; 57: 283-287
63. Haubitz M, Brunkhorst R, Wrenger E, Froese P, Schulze M, Koch KM. Chronic induction of C-reactive protein by hemodialysis, but not by peritoneal dialysis therapy. Peritoneal Dial Int 1996; 16: 158 162
64. Argiles A, Kerr PG, Mourad G, Mion CM, Atkins RC. Serum α2-macroglobulin in haemodialysis patients: baseline and kinetic studies. Nephrol Dial Transplant 1993; 8: 1118 1123
65. Docci D, Bilancioni R, Baldrati L, Capponcini C, Delvecchio C, Feletti C. Serum alpha-1-antitrypsin in hemodialysis patients with dialysis arthropathy. Int J Artif Org 1993; 16: 123 127
66. Docci D, Bilancioni R, Pistocchi E et al. Evolution of serum prealbumin following hemodialysis: effect of different dialysis membranes. Nephron 1992; 62: 145-149